New Delhi, January 3, 2021, SPA -- India's drugs regulator on Sunday gave final approval for the emergency-use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech and a state-run institute, Reuters reported. The decisions mark the first vaccine approvals for the world's second-most populous country, which after the United States, has recorded the most infections of the coronavirus disease. It is now expected to start a massive immunisation programme within about a week, a government official said, and hopes to inoculate 300 million of its 1.35 billion people free of charge in the first six to eight months of this year. --SPA 13:31 LOCAL TIME 10:31 GMT 0004 www.spa.gov.sa/w1477705